Pharmaceutical giant Merck had some exciting news this week, revealing that laboratory studies show that Merck & Co’s experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus. This includes the dominant, highly transmissible Delta. Jay Grobler, head of infectious disease and vaccines at Merck, has said that … Continue reading “Merck Announces that Researches Shows its COVID-19 Pill Works Against Variants”
Biotech & Pharma
Biotech & Pharma
Merck is Reportedly Close to Buying Acceleron Pharma
According to a Wall Street Journal report and sources familiar with the situation, pharma giant…
September 28, 2021
Biotech & Pharma
FDA Authorizes Booster Dose of Pfizer Inc for 65 and Older and Some Others
The U.S. Food and Drug Administration announced this week that it has authorized a booster…
September 23, 2021
Biotech & Pharma
Covid Vaccine Data for Kids Under 5 May Come in Late October Says Pfizer CEO
The world is still grappling with the coronavirus and many parents are anticipating when they…
September 14, 2021
Biotech & Pharma
Moderna Shares Rise as Morgan Stanley Boosts Price Target
Morgan Stanley has increased its price target on Moderna by 77% this week. Shares of…
September 10, 2021
Biotech & Pharma
Booster Shots From Pfizer Likely to Be Ready by September 20th
According to top infectious disease expert Dr. Anthony Fauci, Covid booster shots from pharma giant…
September 6, 2021
Biotech & Pharma
Pfizer Begins to Dose Patients in its Oral Covid-19 Drug Trial
Pharmaceutical giant Pfizer has now started to dose patients in its oral COVID-19 drug trial.…
September 3, 2021
Biotech & Pharma
Moderna is Looking to Get U.S. Authorization for its Covid-19 Vaccine Booster
Moderna asked the U.S. Food and Drug Administration (FDA) on Wednesday to allow the use…
September 2, 2021
Biotech & Pharma
Johnson & Johnson HIV Vaccine Fails Trial
In an effort to mitigate the HIV virus, Johnson & Johnson has a HIV vaccine…
August 31, 2021
Biotech & Pharma
Pfizer-BioNTech Covid Vaccine Gains FDA Approval
It was a big day on Monday for Pfizer and BioNTech, as the Food and…
August 23, 2021
Biotech & Pharma
Pfizer Skyrockets to a Record High for the First Time in Over Two Decades
Shares if biotech giant Pfizer were on a tear on Tuesday, climbing ot a record…
August 10, 2021
Biotech & Pharma
Pfizer Authorizes $1B for Covid-19 Oral Treatment
Pfizer's CEO Albert Bourla has said this week that the company has authorized $1 billion…
July 29, 2021
Biotech & Pharma
This is the New Warning to Be Announced by the FDA on J&J’s Covid Vaccine
According to a newly expected Food and Drug Association (FDA) announcement, there is anew warning…
July 12, 2021
Biotech & Pharma
Pfizer is Developing a Covid Booster Shot to Target the Deadly Delta Variant
Just when it looked like the Coronavirus pandemic was easing up, the Delta variant has…
July 8, 2021